[Federal Register: May 26, 1998 (Volume 63, Number 100)]
[Notices]               
[Page 28512-28513]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26my98-43]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:15 a.m.-6:15 p.m., June 24, 1998; 8:00 a.m.-
4:00 p.m., June 25, 1998.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise a list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) Program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: Agenda items include a summary of the 
meeting on ``Evaluating the Role of Vaccines and Infectious Diseases 
in Autoimmune Disease: Insulin Dependent (Type 1) Diabetes 
Mellitus'; updates on the National Immunization Program; the Vaccine 
Injury Compensation Program; the National Vaccine Program; and HIV 
vaccine. Also on the agenda, a discussion of financial disclosure 
and voting protocol for ACIP; rotavirus vaccine data on differences 
in morbidity by socioeconomic group, update on cost benefit data, 
use of vaccine in premature infants, and rotavirus disease in 
immunocompromised persons; a review of changes in the draft rabies 
vaccine recommendation; computer algorithms for ACIP 
recommendations; hepatitis A vaccine; consolidate resolutions 
currently included in the VFC Program; harmonizing recommendation on 
combination vaccines with the American Academy of Pediatrics and the 
American Academy of Family Physicians; use of lyme disease vaccine; 
progress towards development of a revised influenza recommendation; 
and intravenous immunoglobulin products. Other matters of relevance 
among the Committee's objectives may be discussed.

[[Page 28513]]

    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, M/S D50, Atlanta, 
Georgia 30333, telephone 404/639-7250.

    Dated: May 19, 1998.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 98-13847 Filed 5-22-98; 8:45 am]
BILLING CODE 4163-18-P